Wedbush Initiates Coverage on AngioDynamics (ANGO) with a Neutral; Stock Already Appears Over-Extended
Tweet Send to a Friend
Wedbush initiates coverage on AngioDynamics Inc. (Nasdaq: ANGO) with a Neutral rating. PT $17.50.
Wedbush analyst says, "NanoKnife might turn ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "NanoKnife might turn ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
